The United States insulin delivery devices market is expected to grow at a significant rate during the forecast period. The increasing prevalence of diabetes due to consumption of unhealthy eating habits comprising of junk food and high sugar-containing edible food items and beverages leading to obesity is the major driver for the forecast period. Adoption of a sedentary lifestyle due to long working hours, which leaves less time left for physical activities, is giving rise to a number of diseases.
Changing lifestyle and adopting smoking and drinking is affecting the health condition of patients adversely. Diabetes can be cured by a permanent treatment solution yet, but it can be controlled by taking insulin at the required levels at the right time. Patients suffering from type-1 diabetes require the dose of insulin to maintain the sugar level in the body as patients are not able to produce insulin on their own and require the help of insulin devices.
A strong economic position and well-developed healthcare infrastructure is influencing the growth of the market. Favorable reimbursement policies and support of the government to promote the healthcare industry and increase the affordability of availing healthcare services are also driving factors of the market.
United States insulin delivery devices market is segmented into product type, distribution channel, end-user, regional distribution, and company. Based on end-user, the market can be divided into hospitals & clinics, home care, and others. The home care segment is expected to witness the fastest incremental growth for the forecast period, 2023-2027.
The rise in consumer awareness regarding the adverse effects of diabetes, along with the presence of disposable income, is accelerating the demand for insulin delivery devices. The use of insulin devices at home saves other expenses like visiting costs, doctor’s fees, along the time involved to visit the hospital facility.
The major players operating in the United States insulin delivery devices market are Medtronic USA, Inc., Roche Diagnostics Corporation, Becton, Dickinson and Company, Novo Nordisk Inc., Sanofi-Aventis U.S. LLC, Eli Lilly & Company, Abbott Laboratories, Inc., B. Braun Medical Inc., Tandem Diabetes Care, Inc., Insulet Corporation, among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.
Objective of the Study
- To analyze the historical growth of the market size of United States insulin delivery devices market from 2017 to 2020.
- To estimate and forecast the market size of United States insulin delivery devices market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States insulin delivery devices market based on product type, distribution channel, end user, regional distribution, and company.
- To identify dominant region or segment in the United States insulin delivery devices.
- To identify drivers and challenges for United States insulin delivery devices market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States insulin delivery devices market.
- To identify and analyze the profile of leading players operating in United States insulin delivery devices market.
- To identify key sustainable strategies adopted by market players in United States insulin delivery devices market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of manufacturers across the globe. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers who could not be identified due to the limitations of secondary research. Market insights research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
Market insights research calculated the market size of
Key Target Audience
- Insulin delivery devices manufacturing companies
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to insulin delivery devices market.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | - Product Type
- Distribution Channel
- End User
|
| Regional scope | South-West, Mid-West, North-East |
| Key companies profiled | Medtronic USA, Inc., Roche Diagnostics Corporation, Becton, Dickinson and Company, Novo Nordisk Inc., Sanofi-Aventis U.S. LLC, Eli Lilly & Company, Abbott Laboratories, Inc., B. Braun Medical Inc., Tandem Diabetes Care, Inc., Insulet Corporation. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
